Holistic immunomodulation for small cell lung cancer
Holistic immunomodulation for small cell lung cancer
Potential Biomarkers of Immunotherapy in NSCLC
Comprehensive Genomic Profiling (CGP) Uncovered Potential Biomarkers of Immunotherapy in NSCLC – Good Predictive Markers: TMB-H, BRAF and MET; Poor Predictive Marker: STK11 [1138PD]
Atezolizumab in Combination with Bevacizumab
Atezolizumab in Combination with Bevacizumab in Untreated mRCC: Updated Analysis of IMmotion150 Study [LBA39] Powles T, et al.
Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer
Journal of Thoracic Oncology (2017), doi: 10.1016/j.jtho.2017.10.011.